Literature DB >> 2509374

[Multi-step increase in resistance of Neisseria gonorrhoeae isolates after repeated in-vitro subinhibitory concentrations of second-generation quinolones].

H C Korting1, A Lukacs.   

Abstract

Five recent gonococcal isolates were exposed to subinhibitory concentrations of several antibiotics in vitro 25 times. In the presence of rifampicin all strains quickly became resistant. In the presence of penicillin, enoxacin and ciprofloxacin, antimicrobial susceptibility also decreased. Here development of resistance, however, corresponded to the multi- and not to the one-step type. It seems remarkable that even at the end of the experiments no strain grew at concentrations of ciprofloxacin exceeding 0.064 mg/l. In conclusion, quick development of resistance need not be expected after the introduction of newer quinolones into the therapy of gonorrhoea on a large scale.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2509374     DOI: 10.1007/bf01643626

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  20 in total

1.  [Experimental studies on antibiotic resistance of Neisseria gonorrhoeae].

Authors:  J MEYER-ROHN
Journal:  Hautarzt       Date:  1958-02       Impact factor: 0.751

2.  Studies on the action of penicillin; development of penicilli resistance by gonococcus.

Authors:  C P MILLER; M BOHNHOFF
Journal:  Proc Soc Exp Biol Med       Date:  1945-12

3.  Gonorrhoea in N. Africa and Central Mediterranean.

Authors:  D J Campbell
Journal:  Br Med J       Date:  1944-07-08

4.  The comparative pharmacokinetics of five quinolones.

Authors:  R Wise; D Lister; C A McNulty; D Griggs; J M Andrews
Journal:  J Antimicrob Chemother       Date:  1986-11       Impact factor: 5.790

5.  A double blind study comparing two dosages of enoxacin for the treatment of uncomplicated urogenital gonorrhoea.

Authors:  A Notowicz; E Stolz; B van Klingeren
Journal:  J Antimicrob Chemother       Date:  1984-09       Impact factor: 5.790

6.  Comparative double-blind study of 200- and 400-mg enoxacin given orally in the treatment of acute uncomplicated urethral gonorrhea in males.

Authors:  A H van der Willigen; J C van der Hoek; J H Wagenvoort; H J van Vliet; B van Klingeren; W O Schalla; J S Knapp; T van Joost; M F Michel; E Stolz
Journal:  Antimicrob Agents Chemother       Date:  1987-04       Impact factor: 5.191

7.  Antimicrobial resistance of Neisseria gonorrhoea in Bangkok: is single-drug treatment passé.

Authors:  S Brown; T Warnnissorn; J Biddle; K Panikabutra; A Traisupa
Journal:  Lancet       Date:  1982-12-18       Impact factor: 79.321

8.  Prolonged survival of Neisseria gonorrhoeae in a new liquid medium.

Authors:  S Hafiz; M G McEntegart
Journal:  Br J Vener Dis       Date:  1976-12

9.  Ciprofloxacin in acute male gonorrhea.

Authors:  H Szarmach; H Weuta; J Podziewski; J Skarzynski; A Wronski
Journal:  Arzneimittelforschung       Date:  1986-12

10.  Pharmacokinetic determinants of penicillin cure of gonococcal urethritis.

Authors:  H W Jaffe; A L Schroeter; G H Reynolds; A A Zaidi; J E Martin; J D Thayer
Journal:  Antimicrob Agents Chemother       Date:  1979-04       Impact factor: 5.191

View more
  2 in total

1.  Efficacy and safety of single oral dose sparfloxacin vs ciprofloxacin in acute gonococcal urethritis in males. A multicentre international study.

Authors:  H Moi; P Morel; B Gianotti; D Barlow; I Phillips; C Jean
Journal:  Drugs       Date:  1995       Impact factor: 9.546

Review 2.  Bacterial antibiotic resistance development and mutagenesis following exposure to subinhibitory concentrations of fluoroquinolones in vitro: a systematic review of the literature.

Authors:  Carly Ching; Ebiowei S F Orubu; Indorica Sutradhar; Veronika J Wirtz; Helen W Boucher; Muhammad H Zaman
Journal:  JAC Antimicrob Resist       Date:  2020-09-30
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.